Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Amir, Krivoy,; Roy, Onn,; Yael, Vilner,; Eldar, Hochman,; Shira, Weizman,; Amir, Paz,; Shmuel, Hess,; Roi, Sagy,; Shiri, Kimhi-Nesher,; Ehud, Kalter,; Tal, Friedman,; Zvi, Friedman,; Gil, Bormant,; Sharon, Trommer,; Avi, Valevski,; Abraham, Weizman,

doi:10.1016/j.ebiom.2017.11.027

Public

Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Published in EBioMedicine • Dec 1, 2017

Authors:

Krivoy, Amir

Onn, Roy

Vilner, Yael

Abstract

BACKGROUND: While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vitamin D supplementation on psychiatric, cognitive an...

Subject

Clozapine

Cognition

Metabolic syndrome

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!